Denmark’s government, which has been a consistent supporter of the International AIDS Vaccine Initiative for over two decades, is planning to cut its support.
Denmark has invested over 150 million kroner ($23.3 million) in IAVI since 2001, including 5 million kroner ($777,800) this year. The organization has traditionally received multiyear commitments from the government.
IAVI, a nonprofit scientific research organization, works on developing vaccines and antibodies for HIV, tuberculosis, and other emerging diseases. Funds from Denmark have primarily supported the organization’s HIV research programs, including work on developing vaccines and antibodies to prevent HIV infection, especially mother-to-child transmission.